Tang, Lara
Levy, Tess https://orcid.org/0000-0003-2207-0440
Guillory, Sylvia https://orcid.org/0000-0002-9899-4263
Halpern, Danielle https://orcid.org/0000-0001-6745-1197
Zweifach, Jessica https://orcid.org/0000-0001-5392-8839
Giserman-Kiss, Ivy https://orcid.org/0000-0002-1687-7638
Foss-Feig, Jennifer H. https://orcid.org/0000-0002-1491-8248
Frank, Yitzchak https://orcid.org/0000-0003-0979-1032
Lozano, Reymundo https://orcid.org/0000-0002-5616-5854
Belani, Puneet https://orcid.org/0000-0001-8618-8136
Layton, Christina https://orcid.org/0000-0002-3362-6902
Lerman, Bonnie
Frowner, Emanuel
Breen, Michael S. https://orcid.org/0000-0002-6739-939X
De Rubeis, Silvia https://orcid.org/0000-0001-9383-6883
Kostic, Ana https://orcid.org/0000-0002-1975-6110
Kolevzon, Alexander https://orcid.org/0000-0001-8129-2671
Buxbaum, Joseph D. https://orcid.org/0000-0001-8898-8313
Siper, Paige M. https://orcid.org/0000-0002-9659-8232
Grice, Dorothy E. https://orcid.org/0000-0002-8833-2549
Article History
Received: 26 October 2020
Accepted: 1 March 2021
First Online: 16 May 2021
Declarations
:
: Parents or legal guardians of all participants in this study provided informed consent prior to study participation. This study was approved by the Mount Sinai Institutional Review Board, Program for the Protection of Human Subjects (Study ID: 98–436).
: Additional consent for publication of data was obtained from all parents and guardians. Specific consent for use of all photographs was also obtained.
: A. Kolevzon receives research support from AMO Pharma and consults to Ovid Therapeutics, Acadia, and Sema4. PMS is the inventor of the SAND, which is licensed by Mount Sinai to Stoelting Co. No other competing interests to declare.